Civica will begin selling a type of insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s ...
Non-profit pharmaceutical company Civica will launch an affordable long-acting insulin – insulin glargine-yfgn in pre-filled ...
Lawmakers have focused on the high cost of diabetes drugs. The announcement will make state-branded insulin available two ...
As the first and only state contracting for its own affordable insulin, Governor Gavin Newsom today announced that CalRx® ...
Gov. Gavin Newsom announced Thursday he is rolling out an effort to lower the price of insulin to $11. CalRx, the state-run ...
California will soon become the first state to offer its own affordable insulin, with Gov. Gavin Newsom announcing that CalRx ...
Civica announced today that it plans to launch an affordable long-acting insulin in pre-filled pens starting in January 2026.
The move aims to increase the availability of affordable insulin for the country's 38.4 million diabetes patient ...
The sale of insulin is part of the state’s CalRx initiative aimed at lowering prescription drug prices for Californians.
CARSON CITY — The Nevada Senate passed key bills put forward by Speaker Steve Yeager on Thursday, including one that would cap the cost of insulin at $35 for people on private insurance, and one that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback